Joan Bladé Selected Research

Joan Bladé Research Topics

Disease

140	Multiple Myeloma 02/2024 - 05/2002
15	Disease Progression 01/2021 - 01/2005
12	Immunoglobulin Light-chain Amyloidosis 04/2024 - 01/2006
12	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 05/2002
11	Neoplasms (Cancer) 01/2022 - 07/2004
9	Smoldering Multiple Myeloma 05/2024 - 09/2005
9	Peripheral Nervous System Diseases (PNS Diseases) 10/2014 - 08/2004
8	Paraproteinemias (Monoclonal Gammopathy) 02/2024 - 03/2003
7	Plasmacytoma 01/2022 - 05/2004
6	Amyloidosis 01/2023 - 10/2012
6	Fatigue 04/2016 - 08/2004
6	Thrombocytopenia (Thrombopenia) 01/2015 - 04/2005
6	Renal Insufficiency (Renal Failure) 06/2011 - 08/2004
5	Infections 10/2023 - 01/2005
5	Neutropenia 01/2019 - 10/2008
5	Pathologic Complete Response 01/2014 - 12/2009
4	Residual Neoplasm 09/2021 - 01/2012
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021 - 04/2003
3	Hemorrhage 02/2009 - 02/2008
2	Frailty 04/2024 - 11/2021
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2021
2	Lymphoma (Lymphomas) 01/2021 - 04/2003
2	Asthenia 08/2016 - 10/2014
2	Constipation 05/2012 - 08/2004
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2011 - 04/2008
2	Anemia 02/2010 - 04/2005
2	Plasma Cell Leukemia 10/2008 - 04/2005
2	Necrosis 07/2002 - 05/2002
1	Drug-Related Side Effects and Adverse Reactions 11/2023
1	Genetic Translocation (Chromosomal Translocation) 10/2022
1	Thrombotic Microangiopathies 01/2021

Drug/Important Bio-Agent (IBA)

54	Bortezomib (Velcade)FDA Link 02/2024 - 01/2005
38	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 01/2005
23	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2003
21	Lenalidomide (CC 5013)FDA Link 12/2023 - 04/2008
20	Thalidomide (Thalomid)FDA Link 01/2023 - 03/2003
17	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2005
12	Prednisone (Sone)FDA LinkGeneric 11/2021 - 10/2006
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2012
9	daratumumabIBA 02/2024 - 04/2016
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 10/2008
6	Proteasome InhibitorsIBA 01/2021 - 01/2005
6	liposomal doxorubicin (Doxil)FDA Link 07/2016 - 09/2007
5	Monoclonal AntibodiesIBA 01/2020 - 06/2012
5	1-dodecylpyridoxal (PLD)IBA 07/2016 - 09/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 01/2011
4	Immunoglobulin M (IgM)IBA 01/2023 - 04/2003
4	Amyloid (Amyloid Fibrils)IBA 12/2021 - 10/2014
4	Alkylating AgentsIBA 01/2021 - 05/2006
4	Immunoglobulin G (IgG)IBA 10/2018 - 02/2009
4	Immunomodulating AgentsIBA 10/2017 - 11/2010
4	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2012 - 11/2007
3	carfilzomibIBA 10/2023 - 01/2019
3	melflufenIBA 01/2022 - 09/2020
3	PanobinostatIBA 01/2021 - 10/2013
3	pomalidomideIBA 01/2021 - 05/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2008
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020 - 09/2015
3	Oligoclonal BandsIBA 08/2017 - 12/2009
3	Interleukin-6 (Interleukin 6)IBA 06/2014 - 05/2002
3	Busulfan (Busulfex)FDA Link 01/2013 - 12/2007
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 05/2005
2	Complement System Proteins (Complement)IBA 04/2024 - 01/2021
2	ParaproteinsIBA 01/2022 - 05/2019
2	Chimeric Antigen ReceptorsIBA 12/2021 - 12/2019
2	AminopeptidasesIBA 01/2021 - 09/2020
2	Peptides (Polypeptides)IBA 01/2021 - 09/2020
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 05/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2015 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2015 - 07/2012
2	siltuximabIBA 01/2015 - 06/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2014 - 04/2008
2	thiamine triphosphorate (TTP)IBA 05/2014 - 04/2008
2	CytokinesIBA 09/2011 - 05/2002
2	Cytotoxins (Cytolysins)IBA 01/2011 - 01/2005
1	pro-brain natriuretic peptide (1-76)IBA 04/2024
1	selinexorIBA 02/2024
1	Immunoglobulin D (IgD)IBA 02/2024
1	NucleotidesIBA 10/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	filanesibIBA 01/2021

Therapy/Procedure

64	Therapeutics 12/2023 - 11/2003
30	Stem Cell Transplantation 01/2022 - 05/2006
11	Transplantation 12/2023 - 06/2002
5	Autologous Transplantation 07/2013 - 09/2006
5	Drug Therapy (Chemotherapy) 05/2010 - 12/2005
4	Aftercare (After-Treatment) 01/2022 - 10/2008
4	Hematopoietic Stem Cell Transplantation 12/2018 - 12/2009
2	Kidney Transplantation 11/2021 - 08/2011
2	Salvage Therapy 05/2012 - 08/2004
2	Induction Chemotherapy 01/2011 - 11/2010
2	Hematopoietic Stem Cell Mobilization 02/2009 - 02/2008
1	Intravenous Administration 10/2022
1	Hemodilution 09/2021